Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials

Michael J. Burke, Meenakshi Devidas, Kelly Maloney, Anne Angiolillo, Reuven Schore, Kimberly Dunsmore, Eric Larsen, Len A. Mattano, Wanda Salzer, Stuart S. Winter, William Carroll, Naomi J. Winick, Mignon L. Loh, Elizabeth Raetz, Stephen P. Hunger, Archie Bleyer